Department of Environmental Health Sciences (I.M.-M., K.S., R.A.G., K.E.M., M.G.F., T.R.S., A.E.N., A.N.-A.), Columbia University, New York, NY.
Department of Biostatistics (A.D.-R., M.M., L.V.), Columbia University, New York, NY.
Circulation. 2024 Sep 3;150(10):758-769. doi: 10.1161/CIRCULATIONAHA.124.069414. Epub 2024 Aug 1.
Exposure to metals has been associated with cardiovascular disease (CVD) end points and mortality, yet prospective evidence is limited beyond arsenic, cadmium, and lead. In this study, we assessed the prospective association of urinary metals with incident CVD and all-cause mortality in a racially diverse population of US adults from MESA (the Multi-Ethnic Study of Atherosclerosis).
We included 6599 participants (mean [SD] age, 62.1 [10.2] years; 53% female) with urinary metals available at baseline (2000 to 2001) and followed through December 2019. We used Cox proportional hazards models to estimate the adjusted hazard ratio and 95% CI of CVD and all-cause mortality by baseline urinary levels of cadmium, tungsten, and uranium (nonessential metals), and cobalt, copper, and zinc (essential metals). The joint association of the 6 metals as a mixture and the corresponding 10-year survival probability was calculated using Cox Elastic-Net.
During follow-up, 1162 participants developed CVD, and 1844 participants died. In models adjusted by behavioral and clinical indicators, the hazard ratios (95% CI) for incident CVD and all-cause mortality comparing the highest with the lowest quartile were, respectively: 1.25 (1.03, 1.53) and 1.68 (1.43, 1.96) for cadmium; 1.20 (1.01, 1.42) and 1.16 (1.01, 1.33) for tungsten; 1.32 (1.08, 1.62) and 1.32 (1.12, 1.56) for uranium; 1.24 (1.03, 1.48) and 1.37 (1.19, 1.58) for cobalt; 1.42 (1.18, 1.70) and 1.50 (1.29, 1.74) for copper; and 1.21 (1.01, 1.45) and 1.38 (1.20, 1.59) for zinc. A positive linear dose-response was identified for cadmium and copper with both end points. The adjusted hazard ratios (95% CI) for an interquartile range (IQR) increase in the mixture of these 6 urinary metals and the corresponding 10-year survival probability difference (95% CI) were 1.29 (1.11, 1.56) and -1.1% (-2.0, -0.05) for incident CVD and 1.66 (1.47, 1.91) and -2.0% (-2.6, -1.5) for all-cause mortality.
This epidemiological study in US adults indicates that urinary metal levels are associated with increased CVD risk and mortality. These findings can inform the development of novel preventive strategies to improve cardiovascular health.
金属暴露与心血管疾病(CVD)终点和死亡率有关,但除砷、镉和铅以外,前瞻性证据有限。在这项研究中,我们评估了美国成年人种族多样化的 MESA(动脉粥样硬化多民族研究)队列中基线尿液金属与心血管疾病和全因死亡率的前瞻性关联。
我们纳入了 6599 名参与者(平均[标准差]年龄为 62.1[10.2]岁;53%为女性),基线(2000 年至 2001 年)有尿液金属数据,随访至 2019 年 12 月。我们使用 Cox 比例风险模型来估计基于基线尿液中镉、钨和铀(非必需金属)以及钴、铜和锌(必需金属)水平的 CVD 和全因死亡率的调整后的风险比和 95%置信区间。使用 Cox 弹性网络计算这 6 种金属混合物的联合关联和相应的 10 年生存率差异(95%置信区间)。
在随访期间,1162 名参与者发生 CVD,1844 名参与者死亡。在经过行为和临床指标调整的模型中,与最低四分位相比,最高四分位的 CVD 发病和全因死亡率的风险比(95%置信区间)分别为:1.25(1.03,1.53)和 1.68(1.43,1.96)与镉;1.20(1.01,1.42)和 1.16(1.01,1.33)与钨;1.32(1.08,1.62)和 1.32(1.12,1.56)与铀;1.24(1.03,1.48)和 1.37(1.19,1.58)与钴;1.42(1.18,1.70)和 1.50(1.29,1.74)与铜;1.21(1.01,1.45)和 1.38(1.20,1.59)与锌。与这两个终点都显示出镉和铜呈正线性剂量反应。这 6 种尿液金属混合物的四分位间距增加 1 个单位(IQR)与相应的 10 年生存率差异(95%置信区间)的调整后的风险比(95%置信区间)分别为 1.29(1.11,1.56)和-1.1%(-2.0,-0.05)与 CVD 发病,1.66(1.47,1.91)和-2.0%(-2.6,-1.5)与全因死亡率。
这项在美国成年人中的流行病学研究表明,尿液金属水平与 CVD 风险增加和死亡率升高有关。这些发现可以为制定新的预防策略以改善心血管健康提供信息。